Literature DB >> 26792739

Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.

Lindsey R Robinson1, Sean P J Whelan2.   

Abstract

UNLABELLED: Endogenous retroviruses (ERVs), the majority of which exist as degraded remnants of ancient viruses, comprise approximately 8% of the human genome. The youngest human ERVs (HERVs) belong to the HERV-K(HML-2) subgroup and were endogenized within the past 1 million years. The viral envelope protein (ENV) facilitates the earliest events of endogenization (cellular attachment and entry), and here, we characterize the requirements for HERV-K ENV to mediate infectious cell entry. Cell-cell fusion assays indicate that a minimum of two events are required for fusion, proteolytic processing by furin-like proteases and exposure to acidic pH. We generated an infectious autonomously replicating recombinant vesicular stomatitis virus (VSV) in which the glycoprotein was replaced by HERV-K ENV. HERV-K ENV imparts an endocytic entry pathway that requires dynamin-mediated membrane scission and endosomal acidification but is distinct from clathrin-dependent or macropinocytic uptake pathways. The lack of impediments to the replication of the VSV core in eukaryotic cells allowed us to broadly survey the HERV-K ENV-dictated tropism. Unlike extant betaretroviral envelopes, which impart a narrow species tropism, we found that HERV-K ENV mediates broad tropism encompassing cells from multiple mammalian and nonmammalian species. We conclude that HERV-K ENV dictates an evolutionarily conserved entry pathway and that the restriction of HERV-K to primate genomes reflects downstream stages of the viral replication cycle. IMPORTANCE: Approximately 8% of the human genome is of retroviral origin. While many of those viral genomes have become inactivated, some copies of the most recently endogenized human retrovirus, HERV-K, can encode individual functional proteins. Here, we characterize the envelope protein (ENV) of the virus to define how it mediates infection of cells. We demonstrate that HERV-K ENV undergoes a proteolytic processing step and triggers membrane fusion in response to acidic pH--a strategy common to many viral fusogens. Our data suggest that the infectious entry pathway mediated by this ENV requires endosomal acidification and the GTPase dynamin but does not require clathrin-dependent uptake. In marked contrast to other betaretroviruses, HERV-K ENV imparts broad species tropism in cultured cells. This work provides new insights into the entry pathway of an extinct human virus and provides a powerful tool to further probe the endocytic route by which HERV-K infects cells.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26792739      PMCID: PMC4794671          DOI: 10.1128/JVI.03136-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Endogenous D-type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcriptase.

Authors:  G R Simpson; C Patience; R Löwer; R R Tönjes; H D Moore; R A Weiss; M T Boyd
Journal:  Virology       Date:  1996-08-15       Impact factor: 3.616

2.  Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.

Authors:  J E Johnson; M J Schnell; L Buonocore; J K Rose
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Cell tropism of the simian foamy virus type 1 (SFV-1).

Authors:  A Mergia; N J Leung; J Blackwell
Journal:  J Med Primatol       Date:  1996-01       Impact factor: 0.667

4.  Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus.

Authors:  M A Gonda; F Wong-Staal; R C Gallo; J E Clements; O Narayan; R V Gilden
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

5.  Vesicular stomatitis virus M protein in the nuclei of infected cells.

Authors:  D S Lyles; L Puddington; B J McCreedy
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

6.  Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus.

Authors:  R J Owens; J K Rose
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

7.  Foamy virus vectors.

Authors:  D W Russell; A D Miller
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Jaagsiekte sheep retrovirus utilizes a pH-dependent endocytosis pathway for entry.

Authors:  Pascale Bertrand; Marceline Côté; Yi-Min Zheng; Lorraine M Albritton; Shan-Lu Liu
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

9.  Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones.

Authors:  S P Whelan; L A Ball; J N Barr; G T Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

10.  Distribution of human endogenous retrovirus HERV-K genomes in humans and different primates.

Authors:  S Steinhuber; M Brack; G Hunsmann; H Schwelberger; M P Dierich; W Vogetseder
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

View more
  9 in total

1.  Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1.

Authors:  Henry B Rogalin; Ekaterina E Heldwein
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

Review 2.  Human endogenous retrovirus-K (HML-2): a comprehensive review.

Authors:  Marta Garcia-Montojo; Tara Doucet-O'Hare; Lisa Henderson; Avindra Nath
Journal:  Crit Rev Microbiol       Date:  2018-10-14       Impact factor: 7.624

3.  Expression of HERV-K108 envelope interferes with HIV-1 production.

Authors:  Sandra N Terry; Lara Manganaro; Alvaro Cuesta-Dominguez; Daria Brinzevich; Viviana Simon; Lubbertus C F Mulder
Journal:  Virology       Date:  2017-06-09       Impact factor: 3.616

4.  viGEN: An Open Source Pipeline for the Detection and Quantification of Viral RNA in Human Tumors.

Authors:  Krithika Bhuvaneshwar; Lei Song; Subha Madhavan; Yuriy Gusev
Journal:  Front Microbiol       Date:  2018-06-05       Impact factor: 5.640

5.  Pro-Inflammatory Signaling Upregulates a Neurotoxic Conotoxin-Like Protein Encrypted Within Human Endogenous Retrovirus-K.

Authors:  Domenico Di Curzio; Mamneet Gurm; Matthew Turnbull; Marie-Josée Nadeau; Breanna Meek; Julia D Rempel; Samuel Fineblit; Michael Jonasson; Sherry Hebert; Jennifer Ferguson-Parry; Renée N Douville
Journal:  Cells       Date:  2020-06-30       Impact factor: 6.600

6.  Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins.

Authors:  Jens Mayer; Christian Harz; Laura Sanchez; Gavin C Pereira; Esther Maldener; Sara R Heras; Lyle W Ostrow; John Ravits; Ranjan Batra; Eckart Meese; Jose Luis García-Pérez; John L Goodier
Journal:  Mol Neurodegener       Date:  2018-08-02       Impact factor: 14.195

7.  Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry.

Authors:  Yíngyún Caì; Shuǐqìng Yú; Rohit K Jangra; Elena N Postnikova; Jiro Wada; Robert B Tesh; Sean P J Whelan; Michael Lauck; Michael R Wiley; Courtney L Finch; Sheli R Radoshitzky; David H O'Connor; Gustavo Palacios; Kartik Chandran; Charles Y Chiu; Jens H Kuhn
Journal:  Front Microbiol       Date:  2019-04-26       Impact factor: 5.640

8.  CD164 is a host factor for lymphocytic choriomeningitis virus entry.

Authors:  Mark J G Bakkers; Alex Moon-Walker; Rasmus Herlo; Vesna Brusic; Sarah Hulsey Stubbs; Kathryn M Hastie; Erica Ollmann Saphire; Tomas L Kirchhausen; Sean P J Whelan
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-02       Impact factor: 12.779

9.  Reconstruction of the cell entry pathway of an extinct virus.

Authors:  Lindsey R Robinson-McCarthy; Kevin R McCarthy; Matthijs Raaben; Silvia Piccinotti; Joppe Nieuwenhuis; Sarah H Stubbs; Mark J G Bakkers; Sean P J Whelan
Journal:  PLoS Pathog       Date:  2018-08-06       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.